Form 4: KALA BIO Director Sells Shares to Cover Tax Obligations Under Pre-Arranged Plan

KALA BIO, Inc. Director Mark T. Iwicki sold 10,866 shares of common stock for tax withholding purposes, as disclosed in a recent SEC Form 4 filing.

Summary

• Mark T. Iwicki, a Director of KALA BIO, Inc., reported a sale of company common stock.
• The transaction involved the disposition of 10,866 shares.
• The shares were sold on June 3, 2025, at a weighted average price of $3.74 per share, with individual sales ranging from $3.52 to $4.05.
• The sale was executed under a Rule 10b5-1 trading plan established on November 9, 2020.
• The purpose of the sale was to cover tax withholding obligations arising from the vesting and settlement of restricted stock units (RSUs) granted on May 31, 2023.
• Following this transaction, Mr. Iwicki beneficially owns 269,210 shares of KALA BIO common stock, which includes 154,042 unvested RSUs.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine, pre-planned sale for tax purposes related to equity compensation, not indicative of positive or negative company performance or insider sentiment regarding the company's future prospects.

Positives

• The sale was pre-planned under a Rule 10b5-1 trading plan, indicating a systematic transaction rather than a discretionary sale based on new, non-public information.
• The transaction was explicitly stated to cover tax withholding obligations related to RSU vesting, which is a common and routine event for executives receiving equity compensation.

Negatives

• A director sold shares, which reduces their direct ownership in the company, although it was for tax obligations and not a discretionary sale.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in a director's direct ownership. However, its pre-planned nature under a 10b5-1 plan and stated purpose (tax obligations) mitigate concerns about adverse insider sentiment, suggesting minimal negative impact.

Key Dates

Recommendation

Keywords

KALA BIO, KALA, Form 4, insider trading, stock sale, director, Mark T. Iwicki, restricted stock units, RSU, 10b5-1 plan, beneficial ownership